Clinical application of 2.7M Cytogenetics array for CNV detection in subjects with idiopathic autism and/or intellectual disability
- 27 February 2012
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 83 (2), 145-154
- https://doi.org/10.1111/j.1399-0004.2012.01860.x
Abstract
Qiao Y, Tyson C, Hrynchak M, Lopez‐Rangel E, Hildebrand J, Martell S, Fawcett C, Kasmara L, Calli K, Harvard C, Liu X, Holden JJA, Lewis SME, Rajcan‐Separovic E. Clinical application of 2.7M Cytogenetics array for CNV detection in subjects with idiopathic autism and/or intellectual disability. Higher resolution whole‐genome arrays facilitate the identification of smaller copy number variations (CNVs) and their integral genes contributing to autism and/or intellectual disability (ASD/ID). Our study describes the use of one of the highest resolution arrays, the Affymetrix® Cytogenetics 2.7M array, coupled with quantitative multiplex polymerase chain reaction (PCR) of short fluorescent fragments (QMPSF) for detection and validation of small CNVs. We studied 82 subjects with ASD and ID in total (30 in the validation and 52 in the application cohort) and detected putatively pathogenic CNVs in 6/52 cases from the application cohort. This included a 130‐kb maternal duplication spanning exons 64–79 of the DMD gene which was found in a 3‐year‐old boy manifesting autism and mild neuromotor delays. Other pathogenic CNVs involved 4p14, 12q24.31, 14q32.31, 15q13.2‐13.3, and 17p13.3. We established the optimal experimental conditions which, when applied to select small CNVs for QMPSF confirmation, reduced the false positive rate from 60% to 25%. Our work suggests that selection of small CNVs based on the function of integral genes, followed by review of array experimental parameters resulting in highest confirmation rate using multiplex PCR, may enhance the usefulness of higher resolution platforms for ASD and ID gene discovery.Keywords
This publication has 13 references indexed in Scilit:
- Functional impact of global rare copy number variation in autism spectrum disordersNature, 2010
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesAmerican Journal of Human Genetics, 2010
- High-resolution SNP arrays in mental retardation diagnostics: how much do we gain?European Journal of Human Genetics, 2009
- Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjectsGenetics in Medicine, 2009
- Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridizationBMC Genomics, 2009
- A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizuresNature Genetics, 2008
- Copy number variation in the genome; the human DMD gene as an exampleCytogenetic and Genome Research, 2006
- Duplications in theDMD geneHuman Mutation, 2006
- Molecular karyotyping using an SNP array for genomewide genotypingJournal of Medical Genetics, 2004
- Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disordersJournal of Autism and Developmental Disorders, 1994